Thailand was the first country in SE Asia to legalize cannabis, and it is becoming the hub of the cannabis business in the region, partly thanks to JVs with US-based companies. However, while Thailand might have "first-mover advantage," some believe it is not fully capitalizing on the opportunity, particularly when it comes to promoting Thailand as a cannabis destination to tourists.
Las Vegas-based company Audacious has become the first foreign franchise to jointly open a medical cannabis clinic in Thailand, treating Parkinson’s disease, Alzheimer’s disease, cancer, eating disorders, and insomnia in Bangkok’s tourist area.
“I hope Thailand will become the Silicon Valley of cannabis for Asia,” the clinic’s Thai partner, Julpas Kruesopon, said in an interview,” or, as most people in Thailand call him now, Mister Weed. “I welcome Israeli companies; I welcome European companies. The key is to grow the industry,” Julpas said.
For more news like this, download our free cannabis news app.
The Herbidus Medical Center opened on March 7 along Bangkok’s Sukhumvit Street, lined with restaurants, hotels, massage parlors, go-go bars, and extravagant shopping malls, between exotic and 5-star establishments.
The joint venture between the US and Thailand “makes us, to our knowledge, the first international company with an operational presence in the Asian legal cannabis market,” said Terry Booth, CEO of Audacious, in a statement.
Julpas said their clinic was “absolutely” the first joint cannabis clinic with a foreign company in Thailand.
It will be “an exceptional opportunity to establish the Audacious brand internationally,” Booth said.
“Under the agreement terms, Audacious has no requirement to provide capital for construction, working capital, or other purposes,” the company announced in November.
“Audacious will provide consulting services, operational intelligence including cultivation, manufacturing and product development, and the expansion of brand visibility in Thailand and beyond,” the company said.
“It will help sell Thai products in the United States and Canada,” Julpas said.
Australis Capital Inc (CSE: AUSA) (OTC: AUSAF) – doing business as Audacious – has partnered with Thailand based food manufacturer and distributor NR Instant Produce and its Golden Triangle Health subsidiary, co-founded by Julpas.
“Sleep disturbances seem to be the number one problem for people who come to our clinic,” Julpas said. “We have a THC (tetrahydrocannabinol) oil and a CBD (cannabidiol) oil for which we have entered into a partnership with the Government Pharmaceutical Organization of Thailand, so it’s legal, but above all, it’s clean.”
Doctors at the clinic examine patients and usually hand them a tiny dropper bottle containing a CBD-dominant liquid oil with 0.2% THC.
“All this we charge 1,000 baht (27.34 euros). We buy the bottled oil from the government for 450 baht (12.3 euros). Each customer that comes in, per ticket that we get, costs about 116.52 euros before going out, along with a host of other Thai-made lotions and potions for sale in shop windows,” says Julpas. “And we’re bringing in Audacious products,” he continued.
The profit margin on gummies is around 60%. Logistically, they are is also the easiest thing to get into Thailand given they’re light and have no need for refrigeration.
In 2018, Thailand became the first country to legalize medical cannabis in Southeast Asia. In 2019, just before becoming health minister, Anutin Charnvirakul said Washington’s “political propaganda” in the 1960s and 1970s intentionally misled Thailand into believing cannabis was an “addictive” narcotic.
“During the Vietnam War, the United States announced that cannabis was a narcotic because once all American soldiers had consumed this kind of substance, they could sleep. People were calming down. They didn’t get aggressive,” Mr. Anutin said.
Thailand appears to be reluctant to legalize cannabis for recreational use because it is waiting for Washington to legalize it in the United States, or bank and treaty agreements between the two countries could become problematic.
At least ten legal clinics, overseen by the Ministry of Health and other officials, have treated hundreds of thousands of Thais for common and serious illnesses with CBD-dominant cannabis oil.
In Thailand, there is not enough locally-grown and processed medical-grade cannabis to meet the country’s needs.
For example, Siripatra Daycha, one of Thailand’s top medical cannabis practitioners, is the producer behind Daycha Oil. It is one of the most popular CBD oils distributed by the Ministry of Health.
“Illegally, at least 600,000 people buy cannabis oil from underground producers,” Daycha said in 2020.
“They primarily use a higher THC formula, made public online by Canadian cannabis activist Rick Simpson. Cannabis, including hemp and other products, will soon be further legalized. In July, it (THC and CBD cannabis) becomes a non-narcotic. And we can start shipping products, probably in September,” Julpas said.
Audacious makes much “stronger” THC oil than those in Thailand, and medical establishments could purchase these products in Thailand to treat patients and allow officials to research higher doses. More potent THC treatments would be categorized as “research,” which will be allowed under medical supervision in July, Julpas predicted.
The joint venture also seeks other partners in Thailand to develop non-intoxicating CBD-infused products, including beauty creams, herbal medicines, spa treatments, and beverages. Today, various Thai companies sell similar CBD-dominant products in malls and restaurants, complete with large cannabis leaf logos.
But Thailand is far behind America’s sophisticated cannabis technology. “We are at the very basic beginning of the cannabis business here. There really isn’t a THC cannabis farm like in the United States with quality control,” Julpas said.
It will take some time before Thailand can really reach that level. As a result, Audacious and other U.S. and foreign companies and investors have several opportunities.
Golden Triangle Health recently signed a five-year contract with Khon Kaen University in northeast Thailand to cultivate up to 4 km2 and use the university’s equipment to manufacture CBD and herbal tea, or other hemp products. But Thai education and technology are not developed enough to create medical-grade products on a large scale.
“We need to find a way to extract more efficiently. So far, the performance is not very good. So I think this is a real opportunity for American companies,” Julpas said. “You can only do that with advanced technology. Also, the follow-up of the product, from the seed to the grower, to the flower, to the extraction. There aren’t really many companies in Thailand that can do this. I think that’s something American companies can do,” he continued.
Julpas imagines tourists enjoying medical cannabis “wellness” spas, nestled on tropical beaches and forested hillsides. He says the biggest money is in medical cannabis tourism – not patient visits to clinics.
“The number one market, I really believe, for cannabis consumption in Thailand will not actually be Thai people. Thailand now enjoys a “first-mover advantage” in Asia, as Bangkok’s cannabis laws are the most liberal on the continent. Our tourism slogan is The land of smiles. Well, shoot, give them cannabis. They will really smile!
__
(Featured image by suzukii xingfu via Pexels)
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published by Toute la Thailand, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions, or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
A survey found that women comprise 61% of home cannabis growers, marking a diversion from…
Denmark plans to make its pilot medical cannabis program permanent following its success in treating…
Polish lawmakers have submitted a non-binding petition to Prime Minister Donald Tusk, urging cannabis decriminalization…
The UK medical cannabis market has rapidly grown since legalization in 2018, with private actors…
A new study involving over 23,000 participants in New Zealand found that 60% of people…
The French Ministers of the Interior and Justice announced a comprehensive plan to tackle organized…